Ligand Pharmaceuticals
LGND
#2826
Rank
NZ$10.49 B
Marketcap
NZ$526.49
Share price
0.59%
Change (1 day)
65.05%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$3.90 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total assets are NZ$3.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$2.69 B61.37%
2024-12-31NZ$1.66 B34.15%
2023-12-31NZ$1.24 B3.63%
2022-12-31NZ$1.20 B-36.77%
2021-12-31NZ$1.89 B0.62%
2020-12-31NZ$1.88 B-14.94%
2019-12-31NZ$2.21 B18.09%
2018-12-31NZ$1.87 B98.94%
2017-12-31NZ$0.94 B8.79%
2016-12-31NZ$0.86 B18.16%
2015-12-31NZ$0.73 B123.19%
2014-12-31NZ$0.32 B158.44%
2013-12-31NZ$0.12 B0.54%
2012-12-31NZ$0.12 B-17.97%
2011-12-31NZ$0.15 B57.75%
2010-12-31NZ$97.93 M-49.84%
2009-12-31NZ$0.19 B-33.92%
2008-12-31NZ$0.29 B30.6%
2007-12-31NZ$0.22 B-51.12%
2006-12-31NZ$0.46 B0.55%
2005-12-31NZ$0.46 B-1.21%
2004-12-31NZ$0.46 B-3.56%
2003-12-31NZ$0.48 B-8.2%
2002-12-31NZ$0.52 B86.03%
2001-12-31NZ$0.28 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$358.83 B 9,098.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$358.95 B 9,101.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$253.93 B 6,409.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$170.68 B 4,275.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$35.32 B 805.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$231.65 B 5,838.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$156.40 B 3,909.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$146.00 B 3,642.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$0.19 B-95.07%๐Ÿ‡บ๐Ÿ‡ธ USA